Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by DaveInCalgaryon Feb 19, 2024 10:45am
198 Views
Post# 35887506

Tilray Brands - American Cannabis Update

Tilray Brands - American Cannabis Update
Could the DEA have shown their hand for a 2024 Rescheduling?

"I believe DEA knew they would reschedule to III since before October.

My Take

The INCB met for 4 days last week in Vienna.
 
https://www.incb.org/incb/en/news/press-releases/2024/the-international-narcotics-control-board-concludes-139th-session.html
 
This line struck me as significant.
 
“The Board reviewed its efforts to build the capacity of national authorities to improve the availability of controlled substances for medical and scientific purposes.”
 
Which aligns with the Medical Marijuana and Cannabidiol Research Expansion Act, H.R. 8454 signed into law by Biden in Dec 2022. The law specifically was created to increase access to an uninterrupted supply of marijuana including for specific strains for research purposes.
 
Every year the DEA is required to evaluate the need to increase quotas for Class I drugs for research purposes. In 2023 the DEA had to double the quota for marijuana because of research demand to 6.7 million grams from the 2022 quota, which was 3.2 million grams. It was 2 million grams for 2021. For 2024 there was no increase to the quota for marijuana, despite having increased bulk manufacturers 7 fold from 1 supplier to 7.
 
Last November the DEA increased delta-9 THC quotas from 384,460g to 1,523,040g, while all other THC quotas increased from 15,000g to over 1,000,000g.
 
In my mind there is only one reason the DEA did not propose any increase to marijuana quotas. That is because research quotas only apply to schedule I and II drugs.
 
I think the DEA has known they were going to reschedule to III all along. This doesn’t mean they aren’t still working out all the final details, or holding it back for political reasons. But I definitely think it’s going to happen before October, when they are again required to set quota limits.
 
Some references.
 
https://www.arnoldporter.com/en/perspectives/advisories/2022/12/medical-cannabis research#:~:text=In%20a%20significant%20federal%20policy,(the%20Cannabis%20Research%20Bill).
 
https://www.congress.gov/117/plaws/publ215/PLAW-117publ215.pdf"

Great observation made by a reddit poster Mr molecule
<< Previous
Bullboard Posts
Next >>